Picture of Yichang Hec Changjiang Pharmaceutical Co logo

1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: Yichang Hec Changjiang Pharmaceutical Says Insulin Aspart 30 Injection Obtained Approval For Launch From China NMPA

Nov 8 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd  1558.HK :
    * INSULIN ASPART 30 INJECTION OBTAINED APPROVAL FOR LAUNCH
FROM
CHINA NMPA

Further company coverage:  1558.HK 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Yichang Hec Changjiang Pharmaceutical Co

See all news